Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition

Erstveröffentlichung
2020Authors
Greiner, Jochen
Goetz, Marlies
Hofmann, Susanne
Schrezenmeier, Hubert
Wiesneth, Markus
Wissenschaftlicher Artikel
Published in
Cancer Immunology Immunotherapy. - : Springer, 2020. - ISSN 0340-7004. - eISSN 1432-0851
Link to publication
https://dx.doi.org/10.1007/s00262-020-02490-2Institutions
UKU. Klinik für Innere Medizin IIIInstitut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
DFG Project THU
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
Subject headings
[Free subject headings]: Leukemia-associated antigens (LAA) | Cytotoxic T lymphocytes (CTL) responses | Immune checkpoint inhibition (ICI) | Acute myeloid leukemia (AML) | Colony-forming cells including leukemic progenitor cells (CFC | LPC) | Colony-forming immunoassays (CFI) | ACUTE MYELOID-LEUKEMIA | RHAMM-R3 PEPTIDE VACCINATION | MYELODYSPLASTIC SYNDROME | CANCER | IPILIMUMAB | BIOMARKERS | BLOCKADE | IMMUNOTHERAPY | HETEROGENEITY | THERAPIES[DDC subject group]: DDC 610 / Medicine & health